Developer docs
API playgroundTry for free, no card

Search company profiles

Johnson Fistel

Full company profile

uuid003kpis

Namestring
Johnson Fistel
Legal namestring
Johnson Fistel, PLLP
Websiteurl
johnsonfistel.com
Company typeenum
Private
Founded yearint
2014
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
securities litigation, shareholder class actions, derivative lawsuits, consumer protection litigation, investor rights law
NAICS code1 code
  • Legal Services5411
Product category
Securities Litigation Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Contingency Fee Securities Litigation
TypeProfessional Services
Description

Johnson Fistel operates on a contingency fee basis, representing investors in securities fraud class actions and investigations at no upfront cost to clients. The firm earns fees only upon successful recovery for investors, typical in securities class action litigation. The firm also files lead plaintiff motions in class actions, establishing its role as class counsel when appointed.

globenewswire.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Johnson Fistel, PLLP is a securities litigation law firm representing individual and institutional investors in securities fraud class actions, shareholder derivative suits, merger challenges, and consumer protection cases. The firm operates on a contingency fee basis, meaning clients pay no attorney fees unless the firm recovers damages on their behalf.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Johnson Fistel, PLLP is a securities law firm offering investor rights and litigation services. The firm conducts investigations into potential securities law violations by public companies and facilitates investor recovery through class action litigation, derivative suits, and direct investor representation. Services include securities fraud investigations, breach of fiduciary duty investigations, and shareholder rights advocacy.

Product and service4 records
1Securities Class Action Litigation
CategorySecurities Litigation
Description

Representation of investors as lead plaintiffs or class members in securities fraud class action lawsuits brought against publicly traded companies, their officers, directors, and underwriters for alleged misrepresentations, disclosure failures, or securities law violations.

2Shareholder Derivative Lawsuits
CategorySecurities Litigation
Description

Representation of shareholders in derivative suits brought against corporate officers and directors alleging breaches of fiduciary duty, mismanagement, or self-dealing, with recovery flowing back to the corporation.

3Merger Challenge Litigation
CategorySecurities Litigation
Description

Representation of investors in merger and acquisition disputes, including challenges to unfair deal terms, inadequate disclosures in proxy materials, and breaches of fiduciary duty in change-of-control transactions.

4Consumer Protection Litigation
CategoryConsumer Litigation
Description

Representation of consumers in consumer fraud and consumer protection class action lawsuits involving deceptive trade practices, false advertising, or similar consumer harms.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1Faruqi & Faruqi
TypeDirect peer
Description

Mid-sized securities litigation firm with high-volume investigation announcements and contingency fee practice; directly comparable business model and target market.

2Levi & Korsinsky
TypeDirect peer
Description

Aggressive securities litigation firm known for high-volume investor outreach and press release investigations; one of the closest direct competitors in scale and GTM motion.

3Glancy Prongay & Murray
TypeDirect peer
Description

Active securities class action plaintiffs' firm with similar multi-sector investigation practice and contingency fee model; direct competitor for investor-driven cases.

4Labaton Sucharow
TypeDirect peer
Description

Well-known securities class action plaintiffs' firm with both retail and institutional investor representation; direct peer competing for lead-plaintiff appointments.

5Kessler Topaz Meltzer & Check
TypeDirect peer
Description

Leading mid-sized securities class action firm with similar newswire-driven, multi-sector practice; directly comparable in scale and target case profile to Johnson Fistel.

6The Rosen Law Firm
TypeDirect peer
Description

Investor-rights firm with a high-volume press release approach closely mirroring Johnson Fistel's GTM; directly comparable in targeting retail investors and contingency-fee class actions.

7Bernstein Litowitz Berger & Grossmann
TypeDirect peer
Description

Premier institutional-focused securities litigation firm; competes for lead-plaintiff positions and serves the same investor base in federal securities class actions.

8Pomerantz LLP
TypeDirect peer
Description

Established securities and corporate litigation firm with parallel practice in shareholder class actions and derivative suits; competes for similar case portfolio.

9Robbins Geller Rudman & Dowd
TypeDirect peer
Description

Largest U.S. securities class action plaintiffs' firm; competes directly with Johnson Fistel for lead-plaintiff appointments and operates the same contingency fee, newswire-driven model at much greater scale.

10Bragar Eagel & Squire
TypeDirect peer
Description

Securities litigation and shareholder rights firm that files class actions and derivative suits; closely comparable in size, practice mix, and investor outreach approach.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Johnson Fistel

Securities Litigation Servicesjohnsonfistel.com

Johnson Fistel firmographics

Firmographics
Name
Johnson Fistel
Legal name
Johnson Fistel, PLLP
Website
https://johnsonfistel.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Where Johnson Fistel is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Markets served

Johnson Fistel business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Contingency Fee Securities Litigation: Johnson Fistel operates on a contingency fee basis, representing investors in securities fraud class actions and investigations at no upfront cost to clients. The firm earns fees only upon successful recovery for investors, typical in securities class action litigation. The firm also files lead plaintiff motions in class actions, establishing its role as class counsel when appointed.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels3 records

Johnson Fistel product offering

Product offering

Core offering

Johnson Fistel, PLLP is a securities litigation law firm representing individual and institutional investors in securities fraud class actions, shareholder derivative suits, merger challenges, and consumer protection cases. The firm operates on a contingency fee basis, meaning clients pay no attorney fees unless the firm recovers damages on their behalf.

Product overview

Johnson Fistel, PLLP is a securities law firm offering investor rights and litigation services. The firm conducts investigations into potential securities law violations by public companies and facilitates investor recovery through class action litigation, derivative suits, and direct investor representation. Services include securities fraud investigations, breach of fiduciary duty investigations, and shareholder rights advocacy.

Differentiator

Problem solved

Functional benefit

Products and services

  • Securities Class Action Litigation Representation of investors as lead plaintiffs or class members in securities fraud class action lawsuits brought against publicly traded companies, their officers, directors, and underwriters for alleged misrepresentations, disclosure failures, or securities law violations.
  • Shareholder Derivative Lawsuits Representation of shareholders in derivative suits brought against corporate officers and directors alleging breaches of fiduciary duty, mismanagement, or self-dealing, with recovery flowing back to the corporation.
  • Merger Challenge Litigation Representation of investors in merger and acquisition disputes, including challenges to unfair deal terms, inadequate disclosures in proxy materials, and breaches of fiduciary duty in change-of-control transactions.
  • Consumer Protection Litigation Representation of consumers in consumer fraud and consumer protection class action lawsuits involving deceptive trade practices, false advertising, or similar consumer harms.

Companies that use Johnson Fistel

Customer profile

Segments1 record

Ideal customer profiles1 record

Johnson Fistel technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Johnson Fistel partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves3 records

Expansion highlights4 records

Johnson Fistel competitors and assessment

Company assessment

Direct peers

  • Faruqi & Faruqi: Mid-sized securities litigation firm with high-volume investigation announcements and contingency fee practice; directly comparable business model and target market.
  • Levi & Korsinsky: Aggressive securities litigation firm known for high-volume investor outreach and press release investigations; one of the closest direct competitors in scale and GTM motion.
  • Glancy Prongay & Murray: Active securities class action plaintiffs' firm with similar multi-sector investigation practice and contingency fee model; direct competitor for investor-driven cases.
  • Labaton Sucharow: Well-known securities class action plaintiffs' firm with both retail and institutional investor representation; direct peer competing for lead-plaintiff appointments.
  • Kessler Topaz Meltzer & Check: Leading mid-sized securities class action firm with similar newswire-driven, multi-sector practice; directly comparable in scale and target case profile to Johnson Fistel.
  • The Rosen Law Firm: Investor-rights firm with a high-volume press release approach closely mirroring Johnson Fistel's GTM; directly comparable in targeting retail investors and contingency-fee class actions.
  • Bernstein Litowitz Berger & Grossmann: Premier institutional-focused securities litigation firm; competes for lead-plaintiff positions and serves the same investor base in federal securities class actions.
  • Pomerantz LLP: Established securities and corporate litigation firm with parallel practice in shareholder class actions and derivative suits; competes for similar case portfolio.
  • Robbins Geller Rudman & Dowd: Largest U.S. securities class action plaintiffs' firm; competes directly with Johnson Fistel for lead-plaintiff appointments and operates the same contingency fee, newswire-driven model at much greater scale.
  • Bragar Eagel & Squire: Securities litigation and shareholder rights firm that files class actions and derivative suits; closely comparable in size, practice mix, and investor outreach approach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key highlights6 records

Customer concentration

Johnson Fistel social profiles

Digital presence

Johnson Fistel financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Johnson Fistel leadership team

Management profile

Number of profiles

Profiles2 records

Johnson Fistel funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Johnson Fistel M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Johnson Fistel

What does Johnson Fistel do?

Johnson Fistel, PLLP is a securities litigation law firm representing individual and institutional investors in securities fraud class actions, shareholder derivative suits, merger challenges, and consumer protection cases. The firm operates on a contingency fee basis, meaning clients pay no attorney fees unless the firm recovers damages on their behalf.

Is Johnson Fistel a public or private company?

Johnson Fistel is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Johnson Fistel founded?

Johnson Fistel was founded in 2014. It employs 11 to 50 people.

Where is Johnson Fistel based?

Johnson Fistel is headquartered in San Diego, United States, in the North America region.

How does Johnson Fistel make money?

One revenue line is on record: contingency Fee Securities Litigation.

Who are Johnson Fistel's main competitors?

Direct peers on record are Faruqi & Faruqi, Levi & Korsinsky, Glancy Prongay & Murray, Labaton Sucharow, Kessler Topaz Meltzer & Check, The Rosen Law Firm, Bernstein Litowitz Berger & Grossmann, Pomerantz LLP, Robbins Geller Rudman & Dowd and Bragar Eagel & Squire.

Does Johnson Fistel have an API?

No public API is recorded for Johnson Fistel.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business & FinancialATHR Investor Notice: Johnson Fistel Investigates Aether Holdings, Inc.Johnson Fistel is investigating Aether Holdings after BMF Reports alleged fraud, including lock-up violations and undisclosed insider dealings. The investigation concerns Aether's IPO and its acquisition of AltcoinInvesting.co. Investors who suffered losses are advised to contact the firm.Business & FinancialJohnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut And Accounting DisclosuresSimulations Plus cut its fiscal 2025 revenue guidance to $76–80 million after Q2 results, and shares fell over 24%. The company later reported a $67.3 million net loss including a $77.2 million impairment charge and dismissed Grant Thornton, which cited unresolved accounting issues.PRESSBEEGildan Activewear (GIL) Investor Alert: Johnson Fistel Investigates Following Short-Seller Report ...Middle EastJohnson Fistel, PLLP is investigating Gildan Activewear Inc. on behalf of investors who suffered losses, potentially under federal securities laws. The investigation follows a short-seller report. No further details were disclosed.GurufocusJohnson Fistel, PLLP Investigates Claims on Behalf of Long-TermJohnson Fistel, PLLP announced it is investigating potential claims on behalf of current, long-term DICK'S Sporting Goods shareholders against certain of its officers and directors for alleged breaches of fiduciary duty. The firm noted that on April 3, 2026, a federal court partially denied a motion to dismiss a securities fraud lawsuit, allowing claims over alleged misrepresentations about inventory to proceed.GurufocusCCB Investor Notice: Johnson Fistel Investigates Coastal FinanciJohnson Fistel, PLLP announced it is investigating Coastal Financial Corporation on behalf of investors who suffered losses, asking whether those losses may be recoverable under federal securities laws. The firm cited a July 30, 2026 quarterly net loss of $42.1 million, driven by $68.8 million in credit expenses tied to a banking-as-a-service partner. Shares fell about 43.5% after the disclosure.GurufocusJohnson Fistel, PLLP Investigates Claims on Behalf of Long-TermJohnson Fistel, PLLP announced it is investigating potential claims on behalf of long-term REGENXBIO shareholders against the company's officers and directors for alleged breaches of fiduciary duty. A previously filed federal securities class action alleges defendants made false or misleading statements about RGX-111's Phase I/II trial, omitting safety concerns including a central nervous system neoplasm. The stock fell about 17.8% after the FDA placed the drug on clinical hold on January 28, 2026.FinancialContent Business PageJohnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of DICK’S Sporting Goods, Inc. (DKS)Johnson Fistel, PLLP announced it is investigating potential claims on behalf of current, long-term DICK'S Sporting Goods shareholders against certain officers and directors for alleged breaches of fiduciary duty. The firm noted that on April 3, 2026, a federal court partially denied a motion to dismiss a securities fraud lawsuit, allowing claims over alleged misrepresentations about slowing outdoor segment demand and excess inventory to proceed.FinancialContent Business PageJohnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of REGENXBIO Inc. (RGNX)Law firm Johnson Fistel, PLLP said it is investigating potential claims on behalf of REGENXBIO shareholders against the company's officers and directors for alleged breaches of fiduciary duty. A previously filed federal securities class action alleges defendants made false or misleading statements about RGX-111's Phase I/II trial, omitting safety concerns including a possible central nervous system neoplasm. The firm said shareholders holding shares before February 9, 2022 may have standing to seek reforms, fund returns and a court-approved award.Business Wire BlogJohnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of REGENXBIO Inc. (RGNX)Johnson Fistel, PLLP is investigating potential claims against REGENXBIO officers and directors for alleged breaches of fiduciary duty. The complaint alleges false statements about RGX-111's Phase I/II trial, omitting safety risks, and cites a stock drop from $13.41 to $11.01 after the FDA placed the drug on clinical hold.MorningstarJohnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of REGENXBIO Inc. (RGNX)Johnson Fistel, PLLP is investigating potential claims against REGENXBIO officers and directors for alleged breaches of fiduciary duty. The complaint alleges false statements about RGX-111's trial and concealed safety risks, including a central nervous system tumor that led to an FDA clinical hold, causing a 17.8% stock drop. Shareholders holding shares before February 9, 2022, may have standing to seek reforms.